LENSAR Inc (LNSR)

Currency in USD
4.685
+0.105(+2.29%)
Real-time Data·
LNSR is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
4.4104.870
52 wk Range
4.30012.940
Key Statistics
Prev. Close
4.58
Open
4.59
Day's Range
4.41-4.87
52 wk Range
4.3-12.94
Volume
100.08K
Average Volume (3m)
110.66K
1-Year Change
-54.9952%
Book Value / Share
0.90
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
LNSR Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
11.333
Upside
+141.91%
Members' Sentiments
Bearish
Bullish
ProTips
RSI suggests the stock is in oversold territory

LENSAR Inc News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Neutral
Technical Indicators
Buy
Moving Averages
Sell

Analyst Ratings

3 Buy
0 Hold
0 Sell
Ratings:
3 analysts
Overall Consensus
Strong Buy

Analysts 12-Month Price Target:

Average 11.333
(+141.91% Upside)
Firm
ArticlePositionPrice TargetUpside / DownsideFrom Price TargetActionDate
BTIG
Buy9.00+89.27%10.00MaintainNov 11, 2026
Lucid Capital Markets
Buy11.00+131.34%-New CoverageSep 28, 2026
Lake Street
Buy13.00+173.40%10.00MaintainAug 14, 2026
BTIG
Buy9.00+89.27%7.00MaintainAug 13, 2026
Lake Street
Buy10.00+110.30%-UpgradeApr 01, 2026

LENSAR Inc Earnings Call Summary for Q3/2026

  • LENSAR posted Q3 revenue of $14.13M, down 1% YoY, missing estimates; EPS loss of $0.38 vs. forecast $0.09 loss; shares fell 1.1% premarket.
  • Recurring revenue surged 17% to $12.6M, now 89% of total sales; gross margin expanded to 58% from 42%; adjusted EBITDA turned positive at $1.7M.
  • Procedure volume climbed 12% to 52,545 despite softer cataract market; company placed 10 ALLY systems, reaching ~225 installed base vs. ~185 YoY.
  • Management expects robotic docking feature launch by end of Q1 2027; targeting break-even cash flow in 2027 after $1M-$2M burn in remainder of 2026.
  • International sales disrupted by terminated Alcon deal; CEO cautiously optimistic despite first-ever U.S. cataract market decline, citing product differentiation.
Last Updated: 2026-11-10, 09:26 a/m
Read Full Transcript

Earnings

Latest Release
Nov 10, 2026
EPS / Forecast
-0.38 / -0.09
Revenue / Forecast
14.13M / 14.29M
EPS Revisions
Last 90 days

LNSR Income Statement

Compare LNSR to Peers and Sector

Metrics to compare
LNSR
Peers
Sector
Relationship
P/E Ratio
1.7x3.0x−0.2x
PEG Ratio
0.01−0.190.00
Price/Book
5.1x1.5x2.6x
Price / LTM Sales
0.9x2.5x2.8x
Upside (Analyst Target)
141.6%14.2%60.5%
Fair Value Upside
Unlock21.1%7.8%Unlock

LENSAR, Inc., a commercial-stage medical device company, focuses on designing, developing, and marketing laser systems for the treatment of cataracts and the management of pre-existing or surgically induced corneal astigmatism in the United System, Europe, Asia, South Korea, and internationally. The company offers the LENSAR Laser System, which incorporates a range of proprietary technologies designed to assist the surgeon in obtaining visual outcomes by providing imaging, procedure planning, design, and precision. It also provides ALLY Robotic Cataract Laser System, a compact cataract treatment system that is designed to allow surgeons to perform sterile laser-assisted cataract surgery in a single operating room. LENSAR, Inc. was incorporated in 2004 and is headquartered in Orlando, Florida.

Ownership

Ownership Overview

Type
Common Stock Held% of Shares OutstandingMarket Value
Mutual Funds & ETFs
1.51M12.28%6.91M
Other Institutional Investors
3.96M32.24%18.14M
Public Companies & Retail Investors
6.82M55.48%31.22M
Total
12.29M100.00%56.27M

Top Holders

Holder
% of holding
Shares Held
Date Reported
Value (In 1,000s)
North Run Capital, LP8.96%1,100,5925,041
Brandes Investment Partners, LP8.75%1,075,4004,925

People Also Watch

12.33
WW
-5.52%
246.76
GKOS
-0.16%
28.26
HSTM
-2.15%
67.47
FEIM
-1.11%

FAQ

What Is the LENSAR (LNSR) Stock Price Today?

The LENSAR stock price today is 4.685 USD.

What Stock Exchange Does LENSAR Trade On?

LENSAR is listed and trades on the Nasdaq Stock Exchange.

What Is the Stock Symbol for LENSAR?

The stock symbol for LENSAR is "LNSR."

What Is the LENSAR Market Cap?

As of today, LENSAR market cap is 58.420M USD.

What Is LENSAR's Earnings Per Share (TTM)?

The LENSAR EPS (TTM) is 2.75.

When Is the Next LENSAR Earnings Date?

LENSAR will release its next earnings report on Mar 09, 2027.

From a Technical Analysis Perspective, Is LNSR a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.

How Many Times Has LENSAR Stock Split?

LENSAR has split 0 times.

How Many Employees Does LENSAR Have?

LENSAR has 150 employees.

What is the current trading status of LENSAR (LNSR)?

As of Nov 12, 2026, LENSAR (LNSR) is trading at a price of 4.685 USD, with a previous close of 4.580 USD. The stock has fluctuated within a day range of 4.410 USD to 4.870 USD, while its 52-week range spans from 4.300 USD to 12.940 USD.

What Is LENSAR (LNSR) Price Target According to Analysts?

The average 12-month price target for LENSAR is 11.333 USD, with a high estimate of 13 USD and a low estimate of 10 USD. 3 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Strong Buy. The stock has an +141.91% Upside potential.

What Is the LNSR Premarket Price?

LNSR's last pre-market stock price is 4.630 USD. The pre-market share volume is 761.000, and the stock has decreased by 0.050, or 1.090%.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.